Survival activity of Bcl-2 homologs Bcl-w and A1 only partially correlates with their ability to bind pro-apoptotic family members

Cell Death and Differentiation

Volumn 6, Issue 6, 1999, Pages 525-532

  Holmgreen, Shaun P ^a   Huang, David C S ^a   Adams, Jerry M ^a   Cory, Suzanne ^a  

^a NONE

Author keywords

Apoptosis; Bcl 2 family; Heterodimerization; Mutagenesis

Indexed keywords

GLYCINE; MUTANT PROTEIN; PROTEIN A1; PROTEIN BAD; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL W; PROTEIN BIK; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BINDING AFFINITY; CELL LYSATE; CELL SURVIVAL; CONTROLLED STUDY; DIMERIZATION; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY;

EID: 0032969347     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400519     Document Type: Article

References (57)

1. Kerr JFR, Wyllie AH and Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26: 239-257
2. Strasser A, Huang DCS and Vaux DL (1997) The role of the bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control for tumorigenesis and resistance to chemotherapy. Biochim. Biophys. Acta 1333: F151-F178
3. Adams JM and Cory S (1998) The Bcl-2 protein family: arbiters of cell survival. Science 281: 1322-1326
4. Thornberry NA and Lazebnik Y (1998) Caspases: enemies within. Science 281: 1312-1316
5. Green DR and Reed JC (1998) Mitochondria and apoptosis. Science 281: 1309-1311
6. Zou H, Henzel WJ, Liu X, Lutschg A and Wang X (1997) Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of Caspase-3. Cell 90: 405-413
7. Li P, Nijhawan D, Bdihardjo I, Srinivasula SM, Ahmad M, Alnemri ES and Wang X (1997) Cytochrome c and dATP-dependent formation of Apaf-1/Caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479-489
8. Boise LH, Gonzalez-Garcia M, Postena CE, Ding L, Lindsten T Turka LA, Mao X, Nuñez G and Thompson CB (1993) bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597-608
9. Gibson L, Holmgreen S, Huang DCS, Bernard O, Copeland NG, Jenkins NA, Sutherland GR, Baker E, Adams JM and Cory S (1996) bcl-w, a novel member of the bcl-2 family, promotes cell survival. Oncogene 13: 665-675
10. Lin EY, Orlofsky A, Berger Ms and Prystowsky MB. (1993) Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2. J. Immunol. 151: 1979-1988
11. Choi SS, Park IC, Yun JW, Sung YC, Hong SI and Shin HS (1995) A novel bcl-2 related gene, bfl-1, is overexpressed in stomach cancer and preferentially expressed in bone marrow. Oncogene 11: 1693-1698
12. Kenny JJ, Knobloch TJ, Augustus M, Carter KC, Rosen CA and Lang JC (1997) Grs, a novel member of the Bcl-2 gene family, is highly expressed in multiple cancer cell lines and in normal leukocytes. Oncogene 14: 997-1001
13. Kozopas KM, Yang T, Buchan HL, Zhou P and Craig RW (1993) MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to bcl-2. Proc. Natl. Acad. Sci. USA 90: 3516-3520
14. Oltvai ZN, Milliman CL and Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619
15. Chittenden T, Harrington EA, O'Connor R, Flemington C, Lutz RJ, Evan GI and Guild BC (1995) Induction of apoptosis by the Bcl-2 homologue Bak. Nature 374: 733-736
16. Kiefer MC, Brauer MJ, Powers VC, Wu JJ, Umansky SR, Tomei LD and Barr PJ (1995) Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 374: 736-739
17. Farrow SN, White JHM, Martinou I, Raven T, Pun K-T, Grinham CJ, Martinou J-C and Brown R (1995) Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature 374: 731-733
18. Hsu SY, Kaipia A, McGee E, Lomeli M and Hsueh AJW (1997) Bok is a proapoptotic Bcl-2 protein with restricted expression in reproductive tissues and heterodimerizes with selective anti-apoptotic Bcl-2 family members. Proc. Natl. Acad. Sci. USA 94: 12401-12406
19. Boyd JM, Gallo GJ, Elangovan B, Houghton AB, Malstrom S, Avery B, Ebb RG, Subramanian T, Chittenden T, Lutz RJ and Chinnadurai G (1995) Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene 11: 1921-1928
20. Han J, Sabbatini P and White E (1996) Induction of apoptosis by human Nbk/Bik, a BH3-containing protein that interacts with E1B 19K. Mol. Cell. Biol. 16: 5857-5864
21. L and Bcl-2, displaces Bax and promotes cell death. Cell 80: 285-291
22. Wang K, Yin X-M, Chao DT, Milliman CL and Korsmeyer SJ (1996) BID: a novel BH3 domain-only death agonist. Genes Dev. 10: 2859-2869
23. L. EMBO J. 16: 1686-1694
24. O'Connor L, Strasser A, O'Reilly LA, Hausmann G, Adams JM, Cory S and Huang DCS (1998) Bim a novel member of the Bcl-2 family that promotes apoptosis. EMBO J. 17: 384-395
25. L, is a potent death agonist. J. Biol. Chem. 273: 7783-7786
26. Yang E and Korsmeyer SJ (1996) Molecular thanatopsis: a discourse on the Bcl-2 family and cell death. Blood 88: 386-401
27. L, an inhibitor of programmed cell death. Nature 381: 335-341
28. L-Bak peptide complex: recognition between regulators of apoptosis. Science 275: 983-986
29. Chittenden T, Flemington C, Houghton AB, Ebb RG, Gallo GJ, Elangovan B, Chinnadurai G and Lutz RJ (1995) A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBO J. 14: 5589-5596
30. Kelekar A and Thompson C (1998) Bcl-2 homology domains: the role of the BH3 domain in apoptosis. Trends Cell Biol. 8: 324-329
31. Yin X-M, Oltvai ZN and Korsmeyer SJ (1994) BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369: 321-323
32. Sedlak TW, Oltvai ZN, Yang E, Wang K, Boise LH, Thompson CB and Korsmeyer SJ (1995) Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc. Natl. Acad. Sci. USA 92(17): 7834-7838
33. L. Nature 379: 554-556
34. L. Mol. Cell. Biol. 17: 7040-7046
35. L and Bcl-2. EMBO J. 16: 968-977
36. Fang G, Chang BS, Kim CN, Perkins C, Thompson CB and Bhalla KN (1998) 'Loop' domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis. Cancer Res. 58: 3202-3208
37. Ross AJ, Waymire KG, Moss JE, Parlow AF, Skinner MK, Russell LD and MacGregor GR (1998) Testicular degeneration in Bclw-deficient mice. Nature Genet. 18: 251-256
38. Print CG, Loveland KL, Gibson L, Meehan T, Stylianou A, Wreford N, de Kretser D, Metcalf D, Königen F, Adams JA and Cory S (1998) Apoptosis regulator Bcl-w is essential for spermatogenesis but appears otherwise redundant. Proc. Natl. Acad. Sci. USA 95: 12424-12431
39. Lin EY, Orlofsky A, Wang H-G, Reed JC and Prystowsky MB (1996) A1, a bcl-2 family member, prolongs cell survival and permits myeloid differentiation. Blood 87: 983-992
40. Karsan A, Yee A, Kaushansky K and Harlan JM (1996) Cloning of human Bcl-2 homologue: inflammatory cytokines induce human A1 in cultured endothelial cells. Blood 87: 3089-3096
41. Tomayko MM and Cancro MP (1998) Long-lived B cells are distinguished by elevated expression of A1. J. Immunol. 160: 107-111
42. Hengartner MO and Horvitz HR (1994) Activation of C. elegans cell death protein CED-9 by an amino-acid substitution in a domain conserved in Bcl-2. Nature 369: 318-320
43. Dexter TM, Scott GD, Scolnick E and Metcalf D (1980) Growth of factor-dependent hemopoietic precursor cell lines. J. Exp. Med. 152: 1036-1047
44. Ottilie S, Diaz J-L, Horne W, Chang J, Wang Y, Wilson G, Chang S, Weeks S, Fritz LC and Oltersdorf T (1997) Dimerization properties of human BAD. J. Biol. Chem. 272: 30866-30872
45. L and proapoptotic activity. J. Biol. Chem. 272: 24101-24104
46. Elangovan B and Chinnadurai G (1997) Functional dissection of the proapoptotic protein Bik. Heterodimerization with anti-apoptosis proteins is insufficient for induction of cell death. J. Biol. Chem. 272: 24494-24498
47. Mizushima J and Nagata S (1990) pEF-BOS, a powerful mammalian expression vector. Nucl. Acids Res. 18: 5322
48. Visvader JE, Elefanty AG, Strasser A and Adams JM (1992) GATA-1 but not sclerosis induces megakaryocytic differentiation in an early myeloid line. EMBO J. 11: 4557-4564
49. Huang DCS, O'Reilly LA, Strasser A and Cory S (1997) The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry. EMBO J. 16: 4628-4638
50. Hopp TP, Prickett KS, Price VL, Libby RT, March CJ, Cerretti DP, Urdal DL and Conlon PJ (1988) A short polypeptide marker sequence useful for recombinant protein identification and purification. Biotechnology 6: 1204-1210
51. Grussenmeyer T, Scheidtmann KH, Hutchinson MA, Eckhart W and Walter G (1985) Complexes of polyoma virus medium T antigen and cellular proteins. Proc. Natl. Acad. Sci. USA 82: 7952-7954
52. Wilson IA, Niman HL, Houghten RA, Cherenson AR, Connolly ML and Lerner RA (1984) The structure of an antigenic determinant in a protein. Cell 37: 767-778
53. Huang DCS, Adams JM and Cory S (1998) The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4. EMBO J. 17: 1029-1039
54. Horton RM, Ho SN, Pullen JK, Hunt HD, Cai Z and Pease LR (1993) Gene splicing by overlap extension. Methods Enzymol. 217: 270-279
55. Strasser A, Harris AW, Huang DCS, Krammer PH and Cory S (1995) Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14: 6136-6147
56. Shortman K, Williams N and Adams P (1972) The separation of different cell classes from lymphoid organs V. Simple procedures for the removal of cell debris, damaged cells and erythroid cells from lymphoid cell suspensions. J. Immunol. Meth. 1: 273-287
57. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F and Riccardi C (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Meth. 139: 271-279